Millennium Management’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-20,000
| Closed | -$430K | – | 6751 |
|
|
2023
Q4 | $430K | Buy |
+20,000
| New | +$357K | ﹤0.01% | 4733 |
|
|
2022
Q1 | – | Sell |
-40,000
| Closed | -$3.24M | – | 7618 |
|
|
2021
Q4 | $3.24M | Buy |
+40,000
| New | +$4.01M | ﹤0.01% | 3311 |
|
|
2021
Q3 | – | Sell |
-20,000
| Closed | -$3.32M | – | 7350 |
|
|
2021
Q2 | $3.32M | Buy |
+20,000
| New | +$3.12M | ﹤0.01% | 3320 |
|
|
2020
Q1 | – | Sell |
-21,000
| Closed | -$2.47M | – | 4621 |
|
|
2019
Q4 | $2.47M | Buy |
+21,000
| New | +$2.08M | ﹤0.01% | 2474 |
|
|
2019
Q1 | – | Sell |
-130,900
| Closed | -$5.09M | – | 4399 |
|
|
2018
Q4 | $5.09M | Sell |
130,900
-59,100
| -31% | -$2.63M | 0.01% | 1578 |
|
|
2018
Q3 | $10.8M | Buy |
+190,000
| New | +$11.9M | 0.01% | 1258 |
|
|
2017
Q1 | – | Sell |
-90,000
| Closed | -$6.54M | – | 3911 |
|
|
2016
Q4 | $6.54M | Buy |
90,000
+50,000
| +125% | +$4.28M | 0.01% | 1154 |
|
|
2016
Q3 | $4.18M | Buy |
40,000
+20,000
| +100% | +$1.81M | 0.01% | 1450 |
|
|
2016
Q2 | $1.48M | Buy |
+20,000
| New | +$1.36M | ﹤0.01% | 1951 |
|
Other funds holding NVRO
Millennium Management's NVRO Position: Q2 2025 in Review
Millennium Management sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 331,014 shares — an estimated $1.93M sold.
Millennium Management first reported a position in NVRO in Q4 2014 and held it in 38 quarters. The position peaked at $72.7M in Q3 2017. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- Millennium Management reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- Millennium Management sold 331,014 NEVRO CORP. shares in Q2 2025, an estimated $1.93M.
- Millennium Management first reported a position in NEVRO CORP. in Q4 2014 and held it in 38 quarters.
- Millennium Management's NEVRO CORP. position peaked at $72.7M in Q3 2017.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.